Time to Develop and Predictors for Incidence of Tuberculosis among Children Receiving Antiretroviral Therapy

Table 1

Baseline sociodemographic, clinical, and laboratory characteristics of children received ART in two public hospitals ().

Variables	Categories	Numbers ()	Percent
Sex	Male	204	49
	Female	217	51
Age	≤5 years	46	11
	Between 6 and 10	114	27
	≥11 years	261	62
Residence	Urban	205	48
	Rural	216	51
Family size	≤2	133	31
	3-4	219	52
	5-6	50	11
	≥7	19	5
Hemoglobin	>10 mg/dl	263	63
	≤10 mg/dl	158	38
WHO	Stage I	128	30
	Stage II	147	35
	Stage III	89	21
	Stage IV	57	13
CD4 count	<100	30	7
	101-200	74	7
	≥201	317	75
Functional status	Working	307	72
	Ambulatory	72	17
	Bedridden	42	10
Adherence	Good	224	59
	Fair	121	29
	Poor	56	13
Isoniazid	Took	258	61
	Missed	163	38
Cocotrimoxazole	Took	321	76
	Missed	100	23
Opportunistic infections	Present	126	29
	Absent	295	70
Vaccination	Completed	276	66
	Not updated	76	18
	Defaulted	69	16
TB contact history	Yes	135	32
	No	286	68
Change of AR regiment	Present	85	20
	Absent	336	79
Parental status	Both parent alive	242	57
	Paternal orphan	115	27
	Maternal orphan	38	9
	Both parent orphan	26	6